<p>Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that they have the underlying condition. Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company&#8217;s AI software aims to identify early-stage coronary [&hellip;]</p>

<p>Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design.&nbsp; “Just because a drug isn&#8217;t successful in clinical trials doesn&#8217;t mean it&#8217;s not a [&hellip;]</p>

<p>Decarbonizing our economies in the race to fight climate change demands a wholesale overhauling of all sorts of production processes to make them as sustainable as possible. Greening chemicals, which are used as ingredients in all sorts of products, is where U.K. startup Deep Blue BioTech is putting its energies. The biotech startup founded in [&hellip;]</p>

<p>Decarbonizing our economies in the race to fight climate change demands a wholesale overhauling of all sorts of production processes to make them as sustainable as possible. Greening chemicals, which are used as ingredients in all sorts of products, is where U.K. startup Deep Blue BioTech is putting its energies. The biotech startup founded in [&hellip;]</p>

<p>Vikram Bhaskaran was leading creator partnerships at Pinterest when his father started showing early symptoms of ALS, a rare, terminal neurodegenerative disease. &#8220;It turned my world upside down,&#8221; Bhaskaran said. He worked during the day and spent his evenings googling the illness and treatment options and in Facebook groups. But Bhaskaran discovered that finding clear, [&hellip;]</p>

<p>Vikram Bhaskaran was leading creator partnerships at Pinterest when his father started showing early symptoms of ALS, a rare, terminal neurodegenerative disease. &#8220;It turned my world upside down,&#8221; Bhaskaran said. He worked during the day and spent his evenings googling the illness and treatment options and in Facebook groups. But Bhaskaran discovered that finding clear, [&hellip;]</p>

<p>Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment. Cradle is one of these, focused on protein design — and it just raised $73 million to build out its labs and team. Cradle appeared in 2022 as part [&hellip;]</p>

<p>Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment. Cradle is one of these, focused on protein design — and it just raised $73 million to build out its labs and team. Cradle appeared in 2022 as part [&hellip;]</p>

<p>Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there’s a shortage of expert writers. Paris-based Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. It’s now raised €6 million [&hellip;]</p>

<p>Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there’s a shortage of expert writers. Paris-based Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. It’s now raised €6 million [&hellip;]</p>

<p>OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements along with scientific ways.</p>

<p>Shiva Suri gained a unique perspective into how radiologists work when he quarantined and shared a home office with his mom, a well-regarded radiologist. &#8220;I watched her work day in and day out, and she was wasting about seven to eight hours on boring workflow tasks,&#8221; Suri said. &#8220;Only 5% of her time, she had [&hellip;]</p>

<p>Shiva Suri gained a unique perspective into how radiologists work when he quarantined and shared a home office with his mom, a well-regarded radiologist. &#8220;I watched her work day in and day out, and she was wasting about seven to eight hours on boring workflow tasks,&#8221; Suri said. &#8220;Only 5% of her time, she had [&hellip;]</p>

<p>AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it&#8217;s never quite as straightforward to implement as one would like. Converge Bio has built a tool for companies to make their biology-focused LLMs actually work, from &#8220;enriching&#8221; their data to explaining their answers. The company has raised [&hellip;]</p>

<p>AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it&#8217;s never quite as straightforward to implement as one would like. Converge Bio has built a tool for companies to make their biology-focused LLMs actually work, from &#8220;enriching&#8221; their data to explaining their answers. The company has raised [&hellip;]</p>

<p>Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura&#8217;s Series D funding round and brings the company&#8217;s valuation to more than $5 billion. The partnership paves the way for the two companies&#8217; devices and apps to be used together, which [&hellip;]</p>

<p>You’ve heard of car airbags deploying within milliseconds to protect passengers. How about an airbag for your knee? </p>

<p>Jessica Owens and Iana Dimkova, co-founders of Initiate Ventures, are launching their new healthcare/ life sciences-focused firm with a respectable $45 million debut fund. One of the ways they convinced limited partners to become investors is because they are building a combination early-stage and incubation firm. So not only will they invest in early-stage startups [&hellip;]</p>

<p>Google is committing $20 million in cash and $2 million in cloud credits to a new funding initiative designed to help scientists and researchers unearth the next great scientific breakthroughs using artificial intelligence (AI). The announcement, made by Google DeepMind co-founder and CEO Demis Hassabis during a fireside chat at the closed-door AI for Science [&hellip;]</p>

<p>In a splashy op-ed in Time published this summer, Huffington Post founder Arianna Huffington and OpenAI CEO Sam Altman announced Thrive AI Health, a venture with the goal of building an AI-powered assistant to promote healthier lifestyles. Backed by Huffington’s mental wellness firm Thrive Global and the OpenAI Startup Fund, Thrive AI Health would seek to [&hellip;]</p>